Torrent Pharmaceuticals Ltd (TORNTPHARM) — Voting Results | 7 September 2026 (2 announcements)

Torrent Pharmaceuticals announced that shareholders approved the appointment of Shanti Ekambaram as an Independent Director with 99.98% of valid votes cast in favor, following a postal ballot conducted via e-voting from August 8 to September 6, 2026. The result was confirmed by Chairman Samir Mehta on September 7, 2026, and reported by Scrutinizer Rajesh Parekh.

Torrent Pharmaceuticals announced the outcome of its postal ballot vote on appointing Shanti Ekambaram as an Independent Director. Shareholders approved the resolution with 99.98% voting in favor (1,657 votes representing 34,13,59,869 equity shares) and only 0.02% against (54 votes representing 81,679 shares), meeting the required majority under SEBI regulations. The result was confirmed by Chairman Samir Mehta on September 7, 2026, following scrutiny by Company Secretary Rajesh Parekh.